Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00268710
Status:
COMPLETED
Last Update Posted:
2009-12-07
First Post:
2005-12-21
Brief Title:
Docetaxel in Hormone Refractory Prostate Cancer HRPCWeekly or 3weekly TAX Prednisone in HRPC
Sponsor:
Sanofi
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2006-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-21
First Submit QC Date:
December 21 2005
Study First Post Date:
2005-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-12-04
Last Update Post Date:
2009-12-07
Last Update Post Date Type:
ESTIMATED